Cargando…
A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia
BACKGROUND: A number of studies have revealed that Francisella tularensis (FT) suppresses innate immune responses such as chemokine/cytokine production and neutrophil recruitment in the lungs following pulmonary infection via an unidentified mechanism. The ability of FT to evade early innate immune...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173336/ https://www.ncbi.nlm.nih.gov/pubmed/21819572 http://dx.doi.org/10.1186/1471-2180-11-179 |
_version_ | 1782211944388755456 |
---|---|
author | Jayakar, Himangi R Parvathareddy, Jyothi Fitzpatrick, Elizabeth A Bina, Xiaowen R Bina, James E Re, Fabio Emery, Felicia D Miller, Mark A |
author_facet | Jayakar, Himangi R Parvathareddy, Jyothi Fitzpatrick, Elizabeth A Bina, Xiaowen R Bina, James E Re, Fabio Emery, Felicia D Miller, Mark A |
author_sort | Jayakar, Himangi R |
collection | PubMed |
description | BACKGROUND: A number of studies have revealed that Francisella tularensis (FT) suppresses innate immune responses such as chemokine/cytokine production and neutrophil recruitment in the lungs following pulmonary infection via an unidentified mechanism. The ability of FT to evade early innate immune responses could be a very important virulence mechanism for this highly infectious bacterial pathogen. RESULTS: Here we describe the characterization of a galU mutant strain of FT live vaccine strain (LVS). We show that the galU mutant was highly attenuated in a murine model of tularemia and elicited more robust innate immune responses than the wild-type (WT) strain. These studies document that the kinetics of chemokine expression and neutrophil recruitment into the lungs of mice challenged with the galU mutant strain are significantly more rapid than observed with WT FT, despite the fact that there were no observed differences in TLR2 or TLR4 signaling or replication/dissemination kinetics during the early stages of infection. We also show that the galU mutant had a hypercytotoxic phenotype and more rapidly induced the production of IL-1β following infection either in vitro or in vivo, indicating that attenuation of the galU mutant strain may be due (in part) to more rapid activation of the inflammasome and/or earlier death of FT infected cells. Furthermore, we show that infection of mice with the galU mutant strain elicits protective immunity to subsequent challenge with WT FT. CONCLUSIONS: Disruption of the galU gene of FTLVS has little (if any) effect on in vivo infectivity, replication, or dissemination characteristics, but is highly attenuating for virulence. The attenuated phenotype of this mutant strain of FT appears to be related to its increased ability to induce innate inflammatory responsiveness, resulting in more rapid recruitment of neutrophils to the lungs following pneumonic infection, and/or to its ability to kill infected cells in an accelerated fashion. These results have identified two potentially important virulence mechanisms used by FT. These findings could also have implications for design of a live attenuated vaccine strain of FT because sublethal infection of mice with the galU mutant strain of FTLVS promoted development of protective immunity to WT FTLVS. |
format | Online Article Text |
id | pubmed-3173336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31733362011-09-15 A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia Jayakar, Himangi R Parvathareddy, Jyothi Fitzpatrick, Elizabeth A Bina, Xiaowen R Bina, James E Re, Fabio Emery, Felicia D Miller, Mark A BMC Microbiol Research Article BACKGROUND: A number of studies have revealed that Francisella tularensis (FT) suppresses innate immune responses such as chemokine/cytokine production and neutrophil recruitment in the lungs following pulmonary infection via an unidentified mechanism. The ability of FT to evade early innate immune responses could be a very important virulence mechanism for this highly infectious bacterial pathogen. RESULTS: Here we describe the characterization of a galU mutant strain of FT live vaccine strain (LVS). We show that the galU mutant was highly attenuated in a murine model of tularemia and elicited more robust innate immune responses than the wild-type (WT) strain. These studies document that the kinetics of chemokine expression and neutrophil recruitment into the lungs of mice challenged with the galU mutant strain are significantly more rapid than observed with WT FT, despite the fact that there were no observed differences in TLR2 or TLR4 signaling or replication/dissemination kinetics during the early stages of infection. We also show that the galU mutant had a hypercytotoxic phenotype and more rapidly induced the production of IL-1β following infection either in vitro or in vivo, indicating that attenuation of the galU mutant strain may be due (in part) to more rapid activation of the inflammasome and/or earlier death of FT infected cells. Furthermore, we show that infection of mice with the galU mutant strain elicits protective immunity to subsequent challenge with WT FT. CONCLUSIONS: Disruption of the galU gene of FTLVS has little (if any) effect on in vivo infectivity, replication, or dissemination characteristics, but is highly attenuating for virulence. The attenuated phenotype of this mutant strain of FT appears to be related to its increased ability to induce innate inflammatory responsiveness, resulting in more rapid recruitment of neutrophils to the lungs following pneumonic infection, and/or to its ability to kill infected cells in an accelerated fashion. These results have identified two potentially important virulence mechanisms used by FT. These findings could also have implications for design of a live attenuated vaccine strain of FT because sublethal infection of mice with the galU mutant strain of FTLVS promoted development of protective immunity to WT FTLVS. BioMed Central 2011-08-05 /pmc/articles/PMC3173336/ /pubmed/21819572 http://dx.doi.org/10.1186/1471-2180-11-179 Text en Copyright ©2011 Jayakar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Jayakar, Himangi R Parvathareddy, Jyothi Fitzpatrick, Elizabeth A Bina, Xiaowen R Bina, James E Re, Fabio Emery, Felicia D Miller, Mark A A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia |
title | A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia |
title_full | A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia |
title_fullStr | A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia |
title_full_unstemmed | A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia |
title_short | A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia |
title_sort | galu mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173336/ https://www.ncbi.nlm.nih.gov/pubmed/21819572 http://dx.doi.org/10.1186/1471-2180-11-179 |
work_keys_str_mv | AT jayakarhimangir agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT parvathareddyjyothi agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT fitzpatrickelizabetha agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT binaxiaowenr agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT binajamese agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT refabio agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT emeryfeliciad agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT millermarka agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT jayakarhimangir galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT parvathareddyjyothi galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT fitzpatrickelizabetha galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT binaxiaowenr galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT binajamese galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT refabio galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT emeryfeliciad galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia AT millermarka galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia |